Newly Discovered Protein Facilitates TBE Virus Entry into Brain Cells

Scientists have discovered that the protein LRP8 on cell surfaces is essential for the tick-borne encephalitis (TBE) virus to infect human brain cells, opening new possibilities for targeted treatments.
Researchers from the Karolinska Institutet and international partners have identified a key protein on cell surfaces that is essential for the tick-borne encephalitis (TBE) virus to infect human cells. The study, published in Nature, reveals that the protein LRP8 acts as a critical receptor enabling the virus to cross cellular barriers and invade brain cells. This breakthrough was achieved by exposing a vast library of genetically modified cells to the virus, pinpointing LRP8 as the crucial factor; cells lacking this protein survived infection, indicating its vital role. LRP8 is highly expressed in brain tissue, making it especially relevant to the neurological impacts of TBE.
The virus is predominantly transmitted through tick bites, which can lead to severe neurological diseases. Its prevalence is increasing across Europe and Asia, paralleling the rise in tick populations. Despite the availability of a vaccine, there are no targeted treatments for individuals already infected. As a biosafety level 4 pathogen, TBE requires strict laboratory protocols.
The study demonstrated that the TBE virus’s surface protein specifically binds to LRP8, exploiting this receptor to gain entry into cells—particularly neurons in the brain. Understanding this mechanism opens new avenues for developing antiviral drugs that block this interaction, potentially preventing infection or reducing its severity. Notably, this research marks the first identification of a direct host cell receptor for a flavivirus, a family of viruses that includes yellow fever, dengue, and Japanese encephalitis, which are typically transmitted by mosquitoes or ticks.
Future research aims to understand how LRP8 facilitates the virus’s pathogenic effects within the brain’s neuronal network. The discovery offers hope for innovative therapies that can inhibit the initial stages of TBE virus infection, significantly impacting public health in endemic areas.
Source: https://medicalxpress.com/news/2025-09-key-protein-borne-encephalitis-revealed.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Ancient Fungus from King Tut’s Tomb Reveals Potential Cancer-Fighting Compounds
Research reveals that toxic fungus from King Tut’s tomb produces compounds with potential to fight cancer, transforming a feared organism into a promising medical tool.
Blocking Cell Death Receptor Promotes Mucosal Healing in Inflammatory Bowel Disease
A recent study identifies that inhibiting the TMEM219 cell death receptor can enhance mucosal healing in inflammatory bowel disease, offering new therapeutic prospects.
Liver Fat, Not Weight, Predicts Health Risks in Obese Children
New research reveals that liver fat, rather than weight alone, is a key predictor of health risks in obese children. Monitoring liver health can guide better prevention of metabolic diseases.
Rising Gonorrhea Cases Highlight Challenges of Antibiotic Resistance
Gonorrhea cases are rising worldwide, fueled by increasing antibiotic resistance, making effective treatment more challenging. Researchers are working on new drugs to combat resistant strains and prevent severe health complications.



